Safety and Efficacy of Triple Therapy With Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Human Immunodeficiency Virus Type 2 Patients: Results From a 48-Week Phase 2 Study

AuthID
P-00Y-PBS
21
Author(s)
Pacheco, P
·
Marques, N
·
Rodrigues, P
·
Mansinho, K
·
Maltez, F
·
Janeiro, N
·
Franco, C
·
Trigo, D
·
Batista, J
·
Duque, L
·
[+1]·
Aleixo, MJ
·
Silva, AR
·
Tavares, R
·
Alves, J
·
Peres, S
·
Povoas, D
·
Lino, S
·
Araujo, V
·
Lopes, C
Document Type
Article in Press
Year published
2023
Published
in CLINICAL INFECTIOUS DISEASES, ISSN: 1058-4838
Volume: 77, Issue: 5, Pages: 740-748 (10)
Indexing
Publication Identifiers
Pubmed: 37288954
Scopus: 2-s2.0-85170717511
Wos: WOS:001018618800001
Source Identifiers
ISSN: 1058-4838
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Pacheco, P;   2 Marques, N;   3 Rodrigues, P;
4 Mansinho, K;   5 Maltez, F;   6 Janeiro, N;
7 Franco, C;   8 Trigo, D;   9 Batista, J;
10 Duque, L;   11 Lopes, MJ;   12 Aleixo, MJ;
13 Silva, AR;   14 Tavares, R;   15 Alves, J;
16 Peres, S;   17 Povoas, D;   18 Lino, S;
19 Gomes, P;   20 Araujo, V;   21 Lopes, C;